Thyroid Function Screening in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy
Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2026-01 · 25
DOI: 10.1177/23259582261439968 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the International Association of Providers of AIDS Care (JIAPAC), online erschienen am 02.04.2026. Verfasst von Ana Filipa Bolas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes and Metabolism, Hospital de Curry Cabral, Unidade Local de Saúde de São José, Lisbon, Portugal. Hauptthemen laut MEDLINE: HIV Infections, Thyroid Function Tests, Thyroid Diseases. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
People living with human immunodeficiency virus (HIV) may develop endocrine dysfunction, particularly involving the thyroid gland. Although overt thyroid dysfunction in patients living with HIV is similar to that of the general population, subclinical thyroid dysfunction is significantly more prevalent. This study aims to evaluate the prevalence of changes in thyroid function in patients living with HIV on antiretroviral therapy and to determine whether routine thyroid function testing is warranted.
Methods
Retrospective observational study including 249 people living with HIV on antiretroviral therapy and followed in an Internal Medicine outpatient clinic between 2018 and 2023. Patients with a history of thyroid disease before 2018, those receiving treatment with amiodarone, lithium, interferon, and/or tyrosine kinase inhibitors, and those lacking thyroid function assessment or medical records before 2023 were excluded.
Results
Of the 249 patients, 96.4% showed no abnormalities in thyroid function. Thyroid dysfunction was identified in nine patients (3.6%): four (1.6%) had subclinical hypothyroidism, one (0.4%) Hashimoto's thyroiditis, two (0.8%) antibody-negative hypothyroidism, and two (0.8%) subclinical hyperthyroidism.
Conclusion
The overall prevalence of thyroid dysfunction was low, suggesting no benefit in systematic screening of thyroid function among patients living with HIV on antiretroviral therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetes and Metabolism, Hospital de Curry Cabral, Unidade Local de Saúde de São José, Lisbon, Portugal.
- NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
- Department of Internal Medicine, Hospital de São José, Unidade Local de Saúde de São José, Lisbon, Portugal.
ORCID-Profile: Ana Filipa Bolas, Umbelina Caixas, Paula Bogalho, José Silva-Nunes
Zitieren
APA
Bolas, A. F., Caixas, U., Bogalho, P., & Silva-Nunes, J. (2026). Thyroid Function Screening in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy. Journal of the International Association of Providers of AIDS Care (JIAPAC), 25. https://doi.org/10.1177/23259582261439968
Vancouver
Bolas AF, Caixas U, Bogalho P, Silva-Nunes J. Thyroid Function Screening in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2026;25. doi:10.1177/23259582261439968
BibTeX
@article{Bolas2026,
author = {Bolas, Ana Filipa and Caixas, Umbelina and Bogalho, Paula and Silva-Nunes, José},
title = {Thyroid Function Screening in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy},
journal = {Journal of the International Association of Providers of AIDS Care (JIAPAC)},
year = {2026},
volume = {25},
doi = {10.1177/23259582261439968}
}
EUVIMED